Tag: johnson
-
Patent for J&J’s Remicade invalidated, cheaper version looms
A cheaper version of Johnson & Johnson's top-selling drug, the pricey rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled that a key patent …
-
Patent for J&J’s Remicade invalidated, cheaper version looms
A cheaper version of Johnson & Johnson's top-selling drug, the pricey rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled that a key patent …
-
Britain seeks to fight the fat with soft drinks sugar levy
By Kate Kelland LONDON (Reuters) – Britain on Thursday launched a strategy aimed at curbing childhood obesity by taxing companies which sell sugar-laced soft drinks and investing that money in programmes to encourage physical activity and balanced diets for school children. Urging food and drinks firms to act swiftly to cut sugar in their products,…
-
Britain seeks to fight the fat with soft drinks sugar levy
By Kate Kelland LONDON (Reuters) – Britain on Thursday launched a strategy aimed at curbing childhood obesity by taxing companies which sell sugar-laced soft drinks and investing that money in programmes to encourage physical activity and balanced diets for school children. Urging food and drinks firms to act swiftly to cut sugar in their products,…
-
‘Baar Baar Dekho’ spins Bollywood twist on time and love
It is not easy fusing a cocktail of genres including music, comedy and time travel into a movie, but the leading stars of new Bollywood film “Baar Baar Dekho” hope to convey a multi-faceted love story. “Baar Baar Dekho,” which translates as “Look Again and Again,” centers on Jai (Sidharth Malhotra) and Diya (Katrina Kaif),…
-
Washington, California sue over pelvic mesh implants
SEATTLE (AP) — Washington state and California sued Johnson & Johnson on Tuesday, saying that for years the company misrepresented the risks of vaginal mesh implants it sold to repair pelvic collapse.
-
J&J must pay $72 million for cancer death linked to talcum powder: lawyers
Johnson & Johnson was ordered by a Missouri state jury to pay $72 million of damages to the family of a woman whose death from ovarian cancer was linked to her use of the company's talc-based Baby Powder and Shower to Shower for several decades. In a verdict announced late Monday night, jurors in the…
-
J&J must pay $72 million for cancer death linked to talcum powder: lawyers
Johnson & Johnson was ordered by a Missouri state jury to pay $72 million of damages to the family of a woman whose death from ovarian cancer was linked to her use of the company's talc-based Baby Powder and Shower to Shower for several decades. In a verdict announced late Monday night, jurors in the…
-
Eli Lilly’s diabetes pill takes market share from J&J, Astra
Eli Lilly and Co’s new Jardiance diabetes treatment has begun stealing market share from rival drugs in its class, the company said on Tuesday, bolstered by clinical trial data showing it slashed deaths by 32 percent in patients with Type 2 diabetes. In a three-year study whose results were released last summer, Jardiance became the…
-
J&J leukemia drug cuts death risk vs. chemo in new patients: study
Johnson & Johnson’s and AbbVie’s cancer drug Imbruvica significantly reduced the risk of death and disease progression compared with chemotherapy in previously untreated patients with a type of leukemia in a late stage study, paving the way for an expanded approval of the medicine. In the trial of 269 patients aged 65 and older with…